Coeliac children on a gluten-free diet with or without oats display equal anti-avenin antibody titres

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 1, 2006, Pages 42-47

  Hollén, Elisabet ^a   Peterson, Kajsa Holmgren ^a   Sundqvist, Tommy ^a   Grodzinsky, Ewa ^b   Högberg, Lotta ^a,c   Laurin, Pia ^a,d   Stenhammar, Lars ^a,c   Fälth Magnusson, Karin ^a,d   Magnusson, Karl Eric ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Unit of Research and Development in Local Health Care   (Sweden)

^c Norrköping Hospital   (Sweden)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anti avenin antibodies; Avenin; Coeliac disease; Oats

Indexed keywords

ANTIBODY; AVENIN; AVENIN ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NITRIC OXIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CELIAC DISEASE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FOOD INTAKE; GLUTEN FREE DIET; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; METABOLITE; MONITORING; NUTRITIONAL TOLERANCE; OAT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STANDARD;

ANTIBODIES; AVENA SATIVA; CELIAC DISEASE; CHILD; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; NITRIC OXIDE; PLANT PROTEINS;

EID: 29744434704     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520510023945     Document Type: Article

References (23)

1. Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nature Immunol 2002;2:647-55.
2. Shewry PR, Tatham AS, Kasarda DD. Cereal proteins and coeliac disease. In: Marsh MN, editor. Coeliac disease. Oxford: Blackwell Scientific Publications; 1992. pp 305-48.
3. Kim SI, Charbonnier L, Mossé J. Heterogeneity of avenin, the oat prolamin. Fractionation, molecular weight and amino acid composition. Biochim Biophys Acta 1978;537:22-30.
4. Srinivasan U, Leonard N, Jones E, Kasarda DD, Weir DG, O'Farrelly C, et al. Absence of oats toxicity in adult coeliac disease. Br Med J 1996;313:1300-1.
5. Janatuinen EK, Pikkarainen PH, Kemppainen TA, Kosma V-M, Järvinen RMK, Uusitupa MIJ, et al. A comparison of diets with and without oats in adults with coeliac disease. N Engl J Med 1995;333:1033-7.
6. Janatuinen EK, Kemppainen TA, Pikkarainen PH, Holm KH, Kosma V-M, Uusitupa MI, et al. Lack of cellular and humoral immunological responses to oats in adults with coeliac disease. Gut 2000;46:327-31.
7. Janatuinen EK, Kemppainen TA, Julkunen RJK, Kosma V-M, Mäki M, Heikkinen M, et al. No harm from five-year ingestion of oats in coeliac disease. Gut 2002;50:332-5.
8. Storsrud S, Olsson M, Arvidsson Lenner R, Nilsson L, Kilander A. Adult coeliac patients do tolerate large amounts of oats. Eur J Clin Nutr 2003;57:163-9.
9. Kilmartin C, Lynch S, Abuzakouk M, Wieser H, Feighery C. Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture. Gut 2003;52:47-52.
10. Picarelli A, Di Tola M, Sabbatella L, Gabrielli F, Di Cello T, Anania MC, et al. Immunologic evidence of no harmful effect of oats in celiac disease. Am J Clin Nutr 2001;74:137-40.
11. Lundin KEA, Nilsen EM, Scott HG, Loberg EM, Gjoen A, Bratlie J, et al. Oats induced villous atrophy in coeliac disease. Gut 2003;52:1649-52.
12. Hoffenberg EJ, Haas J, Drescher A, Barnburst R, Osberg I, Bao F, et al. A trial of oats in children with newly diagnosed celiac disease. J Pediatr 2000;137:361-6.
13. Högberg L, Laurin P, Fälth-Magnusson K, Grant C, Grodzinsky E, Jansson G, et al. Oats to children with newly diagnosed coeliac disease: a randomised double blind study. Gut 2004;53:649-54.
14. Hollén E, Högberg L, Stenhammar L, Fälth-Magnusson K, Magnusson KE. Antibodies to oat prolamines (avenins) in children with coeliac disease. Scand J Gastroenterol 2003;38:742-6.
15. Verdon CP, Burton BA, Prior RL. Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP + when the Griess reaction is used to assay for nitrite. Anal Biochem 1995;224:502-8.
16. Sundqvist T, Laurin P, Fälth-Magnusson K, Magnusson KE, Stenhammar L. Significantly increased levels of nitric oxide products in urine of children with coeliac disease. J Pediatr Gastroenterol Nutr 1998;27:196-8.
17. Holmgren Peterson K, Fälth-Magnusson K, Magnusson KE, Stenhammar L, Sundqvist T. Children with celiac disease express inducible nitric oxide synthase in the small intestine during gluten challenge. Scand J Gastroenterol 1998;33:939-43.
18. Ciclitira P. Recent advances in coeliac disease. Clin Med 2003;3:166-9.
19. Coffman RL, Lebman DA, Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol 1993;54:229-70.
20. Burgin-Wolff A, Gaze H, Hadziselimovic F, Huber H, Lentze MJ, Nussle D, et al. Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child 1991;66:941-7.
21. Fälth-Magnusson K, Jansson G, Stenhammar L, Magnuson K-E. Serum food antibodies analyzed by enzyme-linked immunosorbent assay (ELISA) and diffusion-in-gel (DIG)-ELISA methods in children with and without celiac disease. J Pediatr Gastroenterol Nutr 1994;18:56-62.
22. Catassi C, Rossini M, Ratsch IM, Bearzi I, Santinnelli A, Castagnani R, et al. Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study. Gut 1993;34:1515-9.
23. Arentz-Hansen H, Fleckenstein B, Molberg O, Scott H, Koning F, Jung G, et al. The molecular basis for oat intolerance in patients with celiac disease. PLoS Med 2004;1:84-92.